Medicare demo emerges as coverage option for Alzheimer’s drug

June 22, 2021

The decision on how to cover an expensive and controversial new Alzheimer’s drug could be settled by letting Medicare run its own trial to study payment and treatment implications.

Study findings provide new insight into how breast cancer evolves
From the early stages of cell mutations starting in puberty to their manifestations as breast cancer in later years, the entire process has remained shrouded in mystery.
Feeling sexy? Scientists find where lust lives—in mice
The source of desire has long been elusive, the stuff of poets and musicians.
Pediatric ICU admissions for SARS-CoV-2 decreased across waves
Across successive waves of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern (VOCs), there was a decrease in intensive care unit (ICU) admissions across ages, while ventilatory and oxygen support varied by age, according to a study published online Aug. 21 in JAMA Pediatrics.
Lengthy screen time associated with childhood development delays
The amount of screen time spent by one-year-olds is associated with developmental delays. This finding, by researchers at Tohoku University, with collaborators at Hamamatsu University School of Medicine, was published in the journal JAMA Pediatrics.
Medicines360's long and winding, $82 million road to create and distribute $50 birth control
Drugs and medical devices rarely come from the nonprofit world. There are more than 2,600 for-profit pharmaceutical companies in the United States, but only three nonprofits have products on the American market.

Medicare demo emerges as coverage option for Alzheimer’s drug

Recent Posts

JUST IN